News|Articles|July 13, 2026

Defining Supply Chain Impact When Transitioning to Reusable Packaging

Listen
0:00 / 0:00

Key Takeaways

  • Supply-chain objectives should explicitly prioritize product protection, traceability for recalls/loss, circularity, and compatibility with automated material handling systems.
  • Key KPIs include system downtime reduction, decreased product/carton damage, improved shipment security, and compliance-driven reliability and quality consistency under cGMP expectations.
SHOW MORE

ORBIS' Matt Marchetti outlines how pharma companies can define supply chain impact, KPIs, and ROI when transitioning to reusable plastic pallets.

Delivering high-value products safely, sustainably and efficiently from the manufacturing floor to the consumer is more important than ever. As companies across the pharmaceutical landscape continue focusing on security, traceability, sustainability and automation efficiency, reusable plastic pallets are playing an increasingly integral role in supply chain operations.

Reusable plastic pallets provide superior durability, enhanced hygiene and long-term reusability, making them an ideal option for pharmaceutical companies seeking to reduce environmental impact. However, transitioning from single use to reusable packaging requires a strategic shift in how organizations evaluate packaging performance, cost and sustainability outcomes. Understanding and defining the supply chain impact is a crucial step when transitioning to reusable plastic pallets. It requires a multi-faceted approach that involves understanding the goals, determining key performance indicators (KPIs) and implementing solutions based on real-time data insights that drive a strong return on investment (ROI).

Understanding the Goals

The value of transitioning to reusable plastic pallets depends on what the pharmaceutical manufacturer wants to accomplish. In the pharmaceutical industry, security, traceability, sustainability and automation efficiency are critical.

For example, pallets often carry high-value pharmaceutical products, so it is important that cartons and boxes stay fully intact and are not damaged by nails or loose boards associated with wood pallets. The smooth surfaces and contoured edges prevent damage to cartons and ensure product quality and security throughout the supply chain. Traceability is very important, so companies have full visibility throughout the supply chain in the case of a recall or loss. Environmental impact plays a role, as manufacturers seek to drive circularity in their supply chains. And, as manufacturing operations become increasingly more automated, companies require plastic pallet solutions that are designed specifically to be integrated seamlessly with automation.

Determining Crucial KPIs

When evaluating whether to transition to reusable plastic pallets, companies will pay close attention to the most important KPIs and current good manufacturing practices (cGMP’s) for their unique supply chain goals. Potential metrics include less system downtime, impact on the environment, reduced product damage, reliability, quality compliance and enhanced security.

For example, utilizing a reliable, consistent platform can improve efficiencies throughout the supply chain and can be measured in reduction of system downtime when plastic pallets are implemented. When it comes to environmental, life-cycle data enables pharmaceutical companies to compare reusable and single-use packaging to calculate the direct environmental impact in terms of solid waste, energy usage and greenhouse gas emissions. This unbiased analysis provides sustainable, measurable data, as they consider the transition to reusable plastic pallets. Another key metric is product security, which could be measured in the percentage of shipments delivered without tampering, carton damage or seal breaches.

Implementing Solutions and Sharing Results

Successfully implementing a reusable packaging program requires pharmaceutical companies to collect real-time data on operational metrics such as downtime, product damage and environmental impact. Running a pilot with a small subset of plastic pallets will provide valuable information that can be evaluated to determine how removal of substandard pallets could make positive impacts throughout the network.

While some of the tracking can be done in real time, in other instances, conclusions must be drawn based on historical data from past conversions. Armed with these results, the next step is to share them with internal decision makers. Launching any new program involves obstacles but having clear ROI data on hand to support the investment can help overcome them. Engaging their provider about asset management, cleaning, tracking, repair and replenishment is critical to closing the loop and recovering the packaging.

Meeting Both Short-Term Business and Long-Term Goals

The most effective plastic pallet programs are thoughtfully planned, with support of key stakeholders and champions.

Recognizing that the move to reusable plastic pallets represents an investment for many companies, flexible financing options can lower the barriers and help accelerate the return on investment.

Pharmaceutical companies that succeed in transitioning to reusable plastic pallets approach the process with clarity and commitment. They recognize this shift benefits people, the planet and the business as a whole. This requires a mindset to view reusable packaging as a valuable company asset. Beyond protecting products, these assets enhance operational efficiency and product security, transforming packaging from “one more thing to track” into a strategic tool that drives long-term business improvement.

Matt Marchetti is a strategic account manager at ORBIS Corporation.